A proposito di questa notizia, repubblica.it diceva stamattina che il
coreano si e' dimesso


News
Nature 438, 405 (24 November 2005) | doi:10.1038/438405a

Korean stem-cell crisis deepens
David Cyranoski

Fertility specialist admits buying human eggs.

The pressure on stem-cell pioneer Woo Suk Hwang over the way he obtained
human eggs for his research is intensifying — particularly in South
Korea, where he had been a national hero. In the past week, several new
claims have emerged that Hwang may have used eggs that were paid for, as
well as eggs from junior members of his laboratory.

Hwang's team, based at Seoul National University, has produced a string
of landmark papers in stem-cell research, including the first stem cells
obtained from a cloned human embryo (W. S. Hwang et al. Science 303,
1669–1674; 2004) and the first patient-matched embryonic stem cells (W.
S. Hwang et al. Science 308, 1777–1783; 2005).

Recently, his research has been overshadowed by allegations about the
way he obtained eggs, but until now these have come from outside his
home country. In 2004, Nature published a claim that Hwang's group had
used eggs from one of his graduate students — a charge Hwang has
constantly denied (see Nature 429, 3; 2004). The student later withdrew
her claim. Then two weeks ago, Hwang's close friend and collaborator
Gerald Schatten of the University of Pittsburgh, Pennsylvania, broke off
ties. He accused Hwang of possible ethical irregularities and
misrepresentations regarding egg donation, although he gave no other
details (see Nature 438, 262–263; 2005).

Now further claims of possible impropriety are arising closer to home.
On 21 November, Sun Il Roh, a fertility expert at MizMedi Hospital in
Seoul, gave a press conference at which he admitted that 20 eggs that he
had procured and given to Hwang for his 2004 study were paid for.
According to Korean newspaper reports, Roh said he paid 1.5 million won
(US$1,430) of his own money to each of the 20 women whose eggs were used
in the experiment. Quoted in the JoongAng Daily, he says: "This is not a
large amount of money, considering that they had to receive injections
every day for 8–10 days." But Roh, who was a co-author on Hwang's 2005
paper, insists that Hwang did not know the status of the eggs he
received. Roh did not respond to Nature's requests for an interview.

Although buying eggs for research was not illegal when the eggs were
procured in 2003, the practice is hugely controversial, and has been
illegal in Korea since last January. Supplementary material to Hwang's
2004 paper clearly states that all egg donors were volunteers.

On 22 November, as Nature went to press, Seoul-based Munhwa Broadcasting
Corporation (MBC) was to run an investigative programme that it said
would show further evidence that Hwang used eggs from junior members of
his lab. Obtaining eggs from a graduate student is problematic because
of the risk that personal pressure could be applied.

According to an MBC producer, the programme was to produce medical
records of egg donors from MizMedi Hospital. The records allegedly show
that at least one of the donors was a researcher in Hwang's lab. MBC
says the researcher in question is not the student who last year told
Nature she had donated eggs at MizMedi, before withdrawing the claim.

Furthermore, an informer, who MBC says is closely linked to Hwang's lab,
allegedly provided the station with experimental notes containing the
donor's name, patient number and the date the eggs were used. MBC claims
these details match the MizMedi medical reports.

The Chosun Ilbo on Tuesday cited another source claiming that eggs from
two researchers in Hwang's lab were used. One was "a graduate student
who invented a new way of removing the nucleus from eggs and is now
working at a research institute in a US university", it said.

Hwang has not replied to Nature's repeated requests for an interview.

The effects of the allegations on the stem-cell field and on Hwang's
research are unclear. On 15 November, after the news of Schatten's
separation, the Korean government laid out plans to invest 11.5 billion
won in the World Stem Cell Hub, an international research network to
have been led by Hwang. But it also proposed to detach the hub from
Seoul National University and make it an independent body. Many
potential overseas collaborators have said their plans are on hold until
the allegations are resolved.

How these events will affect Hwang's team's ability to publish is
another open topic. "It's pretty clear that the editor of any journal
would be on heightened alert if they received a piece of work from them,
and would probably scrutinize it very carefully for the ethics of the
work at the very least," says Gregory Curfman, executive editor of The
New England Journal of Medicine.

"If it turned out that deliberate falsifications had been communicated
to us in connection with that paper we would certainly have to make an
announcement of that," says Donald Kennedy, editor-in-chief of Science,
which published the work. "We would certainly say something about the
caution with which we would treat future communications from that group."

Most are holding out for a revelatory statement from Schatten or Hwang,
who has been rumoured to be planning a press conference this week. "I
hope Dr Hwang will give us the whole story," says Kennedy. "There's a
different onus on Schatten — he has issued a dramatic statement and he's
leaving it like a dead seal on our collective desks."

Top
--
www.e-laser.org
Laser@inventati.org

Rispondere a